Medexus Pharmaceuticals Inc. (MEDXF)

Medexus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	8.44	5.26	13.07	10.02	18.7	5.23
Cash & Short-Term Investments	8.44	5.26	13.07	10.02	18.7	5.23
Cash Growth	2.78%	-59.79%	30.46%	-46.44%	257.42%	-82.08%
Accounts Receivable	14.14	23.87	21.97	13.39	18.4	14.74
Other Receivables	-	0.16	0.41	1.02	0.43	0.22
Receivables	14.14	24.03	22.38	14.41	18.83	14.96
Inventory	34	30.77	22.85	21.35	14.67	14.08
Prepaid Expenses	9.77	10.14	12.38	2.06	4.71	4.35
Other Current Assets	0.37	2.3	2.3	1.28	1.67	1.11
Total Current Assets	66.72	72.5	72.97	49.11	58.57	39.73
Property, Plant & Equipment	0.71	0.78	0.9	1.22	0.8	1.1
Goodwill	9.99	10.28	10.28	10.69	10.65	10.06
Other Intangible Assets	59.29	64.14	70.37	76.57	76.36	69.77
Long-Term Deferred Tax Assets	9.26	8.04	6.81	-	-	-
Other Long-Term Assets	-	-	-	1.64	2.13	2.12
Total Assets	145.98	155.73	161.33	139.23	148.51	122.77
Accounts Payable	39.75	7.75	10.16	12.05	14.86	8.9
Accrued Expenses	-	35.48	23.26	17.13	12.47	13.28
Current Portion of Long-Term Debt	17.75	15.56	42.71	15.05	10.57	10.19
Current Portion of Leases	-	0.19	-	-	-	-
Current Income Taxes Payable	1.71	1.32	1.18	0.03	0.51	0.68
Other Current Liabilities	7.15	5.94	6.19	3.86	1.53	1.1
Total Current Liabilities	66.35	66.23	83.5	48.11	39.94	34.16
Long-Term Debt	21.74	33.8	26.78	39.03	34.09	28.05
Long-Term Leases	0.43	0.35	0.6	0.78	0.21	0.56
Long-Term Deferred Tax Liabilities	-	-	-	1.52	2.65	6.48
Other Long-Term Liabilities	24.36	25.03	28.01	31.99	53.61	29.25
Total Liabilities	112.88	125.41	138.88	121.43	130.5	98.5
Common Stock	76.79	76.39	69.01	68.69	66.69	44.76
Additional Paid-In Capital	11.9	12.01	11.31	10.38	9.5	7.04
Retained Earnings	-61.44	-64.24	-64.03	-65.25	-62.37	-34.11
Comprehensive Income & Other	5.85	6.17	6.16	3.97	4.2	6.58
Shareholders' Equity	33.1	30.32	22.45	17.79	18.02	24.28
Total Liabilities & Equity	145.98	155.73	161.33	139.23	148.51	122.77
Total Debt	39.91	49.9	70.08	54.86	44.87	38.8
Net Cash (Debt)	-31.47	-44.64	-57.01	-44.84	-26.17	-33.56
Net Cash Per Share	-1.27	-1.99	-2.78	-2.26	-1.72	-2.34
Filing Date Shares Outstanding	32.26	24.46	20.25	19.95	19.17	14.45
Total Common Shares Outstanding	24.7	24.46	20.18	19.95	19.17	14.45
Working Capital	0.37	6.27	-10.53	1	18.63	5.57
Book Value Per Share	1.34	1.24	1.11	0.89	0.94	1.68
Tangible Book Value	-36.18	-44.09	-58.21	-69.46	-69	-55.55
Tangible Book Value Per Share	-1.46	-1.80	-2.88	-3.48	-3.60	-3.84
Machinery	1.21	1.12	1.07	1.06	0.96	0.85

Source: S&P Capital IQ. Standard template. Financial Sources.